Trials / Completed
CompletedNCT00649233
Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopressor HCT® Tablets 100/50 mg
Single-Dose Food In Vivo Bioequivalence Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets (100/50 mg; Mylan) to Lopressor HCT® Tablets (100/50 mg; Novartis) in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Mylan Pharmaceuticals Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to investigate the bioequivalence of Mylan metoprolol tartrate/hydrochlorothiazide 100/50 mg tablets to Novartis Lopressor HCT® 100/50 mg tablets following a single, oral 100/50 mg (1 x 100/50 mg) dose administration under fed conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg | 100/50mg, single dose fed |
| DRUG | Lopressor HCT® Tablets 100/50 mg | 100/50mg, single dose fed |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2003-02-01
- Completion
- 2003-02-01
- First posted
- 2008-04-01
- Last updated
- 2024-04-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00649233. Inclusion in this directory is not an endorsement.